期刊文献+

甲壳低聚糖对NOD鼠糖尿病的预防作用 被引量:3

The Effect of Chitooligosaccharides on Preventing the On set of Diabetes in NOD Mice
下载PDF
导出
摘要 目的 :探讨甲壳低聚糖对NOD鼠糖尿病的预防作用机制。方法 :将 5周龄未发病的NOD小鼠分为糖尿病预防组和对照组。预防组用 3 %甲壳低聚糖溶液作饮用水 ,对照组用冷开水作饮用水 ,连续 15周 ,定期测血糖 ,称体重 ,实验末计算糖尿病的发病率 ,HE染色观察胰岛炎。结果 :对照组 12周龄即出现高血糖 ,而预防组至实验结束仅有少数出现高血糖 ,两组相比具有显著差异性 (P <0 0 1)。NOD鼠预防组糖尿病发病率 (2 5% )低于对照组 (79% ) (P <0 0 5) ,同时减轻胰岛炎的严重程度 (P <0 0 5)。结论 :甲壳低聚糖对NOD鼠糖尿病的确有预防作用 ,其机制可能与甲壳低聚糖的非特异性免疫调节作用 ,及抗氧化等有关。 Objective:To explore the effect of chitooligosaccharide s on preventing the onset of diabetes in NOD mice.Methods: 5-week-old NOD mice were divided into a diabetic preventing group and a diabetic control gr oup.The preventing group and the control group received 3% chitooligosaccharides and cool water as drinking water for 15 weeks respectively.Then these mice were measured blood glucose and body weight.At the end of the experiment,the inciden ce of diabetes was investigated in NOD mice,insulitis was observed by HE stainin g.Results:In the control group,these 12-week-old mice appeared hyper g lycemia.However,in the preventing group,only a few mice had appeared hyperglycem ia by the end of the test.The blood glucose level in the diabetic preventing group was significantly lower than that in the control group(P<0 01).The i ncidence of diabetes in the preventing group was 25% which was lower than 79% in the control group (P<0 05),and the degree of insulitis was also less tha n that in the control group (P<0 05).Conclusion:Chitooligosacc harides prevents NOD mice from developing type 1 diabetes,which may be related t o immunopotentiation and antioxidation of chitooligosaccharides.
机构地区 南华大学
出处 《医学理论与实践》 2004年第1期1-3,共3页 The Journal of Medical Theory and Practice
关键词 甲壳低聚糖 NOD鼠 糖尿病 预防作用 Chitooligosaccharides,Type 1 diabetes,NOD mice
  • 相关文献

参考文献4

二级参考文献20

  • 1郭淑玲.合成免疫佐剂在宿主非特异性免疫刺激和增强疫苗免疫原性中的应用[J].国外医药(抗生素分册),1994,15(6):460-464. 被引量:1
  • 2叶春婷,马福广,刘锡麟,徐国风,邹翰.CGG人工皮肤的研制[J].广州医药,1995,26(2):52-53. 被引量:8
  • 3魏涛 唐粉芳 国豫 等.壳聚糖降脂、降糖、增强免疫作用研究[A]..中国甲壳资源研究开发应用学术研讨会论文集[C].,1997.11.
  • 4.GB15193.保健食品功能学评价程序和检验方法[S].中华人民共和国卫生部,..
  • 5Caloinaro F, Gambelunghe G , Lafferty KJ. Protection from autoimmune diabetes by adjuvant therapy in the nonobese diabetic mouse: the role of interleukin - 4 and inerleukin - 10[J]. J Immunol, 1993,150:2072 - 2080.
  • 6Ormrod DJ, Holmes CC, Miller TE. Dietary chitosan inhibit shypercholeaterolaemia and atherogenesis in the aplipoprote in E - dificient mouse model of atherosclerosis[J]. Atherosclerosis, 1998,138(2) :329.
  • 7Lim BO, Yamada K,Nonaka M,et al. Dieary fiber modulate indeces of intestinal immune function in rats[J]. Nutrition, 1997,127(5):663.
  • 8Hoekstra A, Struszczyk H, Kivek O. Percutaneous microcrystalline chitosan application for sealing arterial puncture sites[J]. Biomaterials, 1998,19(16) : 1467.
  • 9Kasapoglu M,Ozben T.Alterations of antioxidant enzymes and oxidative stress markers in aging[J].Exp Gerontology,2001,36(2),209
  • 10Finkel T,Holbrook.Oxidants,oxidative stress and the biology of aging[J].Nature,2000,408(6809) :239.

共引文献15

同被引文献77

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部